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Celiac disease (CD) is a malabsorptive disorder precipitated in genetically sus-
ceptible individuals by ingestion ofgluten. A significant part of the disease predispo-
sition maps to the HLA class II region, but the primary HLA association is not
known (1). DR3 seems to be a susceptibility allele together with any other DR allele
while DR7 is associated to CD almost only in combination with DR3 or DR5 (2, 3).
The HLA-DR3DQw2 haplotype demonstrates the strongest association to CD
(1-5) . We investigated whether DR3DQw2 negative patients might share parts of
the genetic information ofthis HLA haplotype but encoded in trans position. When
we compared amino acid sequences of different DQa and DQß chains we found
that the DQa chain encoded by the DR3DQw2 haplotype is identical to that en-
coded by DR5DQw7 (6, 7), while the DQß chain of the DR3DQw2 haplotype is
identical to that of DR7DQw2 except for a single aminoacid difference in the second
domain (8, 9; Lee, J. S., personal communication). The pairing of a and ß chains
seems to be determined by amino acid residues located in the first domains (10).
Thus, individuals wao are DR5DQw7/DR7DQw2 heterozygous may by transcom-
plementation express the same (or almost the same) DQ a/0 heterodimers as those
formed by DQAl and DQBI genes in cis position on the DR3DQw2 haplotype (see
Fig. 1). As a first step to confirm this hypothesis we typed 94 CD children with syn-
thetic DQA1 and DQB1 allele-specific oligonucleotide (ASO) probes. Here we re-
port that all except one ofthese CD patients carry DQAI and DQB1 genes that may
encode the same DQ a/ß heterodimer.
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Patients andNormal Controls.
￿
The CD patients were 94 unrelated Norwegian children. The
diagnosis of CD was made according to the ESPGAN criteria (11). 56 subjects attending to
the local blood bank served as normal controls.
Serological HLA Typing.
￿
HLA-DR typing was performed on class II-positive cells enriched
from peripheral blood by immunomagnetic isolation (12). Highly selected International Work-
shop (IWS) antisera were used for typing.
Allele-speck Oligonucleotide (ASO) Probes.
￿
The DQAl-2 probe with the sequence 5'-TTA-
ATCAGACTGTTCAAGTT is complementary to the sense strand (amino acid positions 72-78
according to numbering used in reference 13) ofthe DQAl gene ofDR3DQw2 and DR5DQw7
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(6, 7). This probe was kindly synthesized by E. Hornes (AL Lab, Oslo, Norway). The DQBI-2
probe is identical to the sense strand (amino acid positions 26-33) of the DQBI gene of
DR3DQw2 and DR7DQw2 (8,9) and has the sequence 5'-TGTGAGCAGAAGCATCTATA.
This probe was obtained from Genetic Designs (Houston, TX). The probes were enlabeled
to a specific activity of 1.5 x 107 cpm/pmol by T4 polynucleotide kinase using y-[_32P]ATP.
Oligonucleotide Hybridization. DNA was prepared from citrated blood or from EBV-
transformed B cells (one patient and all IWS cell lines). Digestion of DNA (7 4g) was done
with Taq I restriction endonuclease (4 U/tig DNA) as recommended by the manufacturer
(Amersham Corp., Amersham, UK). Restriction fragments were separated by gel electropho-
resis using 0.8% agarose. The gels were then dried and hybridized using conditions mainly
as described previously (14). Hybridizations were performed at the following temperatures:
DQAI-2, 50°C and DQBI-2, 54°C . The allele-specific reactivity of the probes was tested on
Taq I digests from a selected panel of 31 10th IWS cell lines. The DQAI-2 probe hybridized
to a single 4.6-kb DNA fragment only from DR3DQw2, DRwIIDQw7, DRw12DQw7,
DRw14DQw7, and DRw16DQw7 homozygouscells, whereas the DQBI-2 probe hybridized
to a single 1.5-kb fragment only from DR3DQw2 and DR7DQw2 cells.
Results and Discussion
Serological DR typing revealed that 90 of 94 (95.7%) of the CD patients were
DRY of which 27 were heterozygous DR3/7. Three ofthe four DR3- patients were
DR5/7 (two DRwll/7, one DRw12/7), while the remaining patient was DR4/w6.
We then tested Taq I digests of DNA from 94 CD patients and healthy controls
with the ASOs. The DQAI-2 and DQBI-2 probes hybridized to DNA from all CD
patients except the DR4/DRw6 patient (Table I, Fig. 2). In comparison, these probes
hybridized to DNA from 14 out of 56 (25.0%) healthy controls (Table I). The data
suggest that almost all CD patients share a particular combination of a DQA1 and
a DQBI gene ; i.e., they may share a particular cts- or trans-encoded DQa/ß hetero-
dimer (Fig. 1). A similar conclusion was recently reached by others based on studies
of restriction fragment length polymorphism (15). The results ofserological DQtyping
of CD patients are also compatible with our findings (3); DR5/7 CD patients al-
ways carry a DR7DQw2 haplotype, while DR3/7 CD patients may either carry a
DR7DQw2 or a DR7DQw3 haplotype as the disease susceptibility DQ genes are
represented by the DR3DQw2 haplotype.
In our material 95 .7% of the CD patients were DR3 + and 3.2% were DR5/7
heterozygous . The low frequency of DR5/7 correlates with a low frequency of this
phenotype in the normal Norwegian population (0.9%, our unpublished observa-
tion). In contrast, an Italian study has revealed that almost 30% of the CD patients
are DR5/7+, whereas the corresponding frequency in the normal population ap-
TABLE I
Frequencies of Reactivity of the DQAI-2 and DQBI-2 ASO Probes
with DNA from CD Patients and Normal Controls
Reactivity with probes
CD
(n =
patients
94)
Normal
(n =
controls
56)
+ % + 0 /0
DQAI-2 93 98.9 17 30.4
DQBI-2 93 98.9 21 37 .5
DQAI-2 and DQBI-2 93 98.9 14 25.0DR3DQw2
SOLLID ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
347
D081 DQA1
￿
DQBI DQA1
DR7DQw2
DR5DQw7
FIGURE 1 . Schematic representation of
structural and possible evolutionary rela-
tionship between HLA-DQA1 and-DQB1
genes oftheDR3DQw2, DR5DQw7, and
DR7DQw2 haplotypes . Boxes with equiv-
alent shading represent identical or almost
identical genes .
pears to be N8% (3). Parallel results have been obtained in a Spanish study (2) . The
frequency of DR3 and DR5/7 among CD patients thus seems to be correlated to
thenormal frequency ofthese phenotypes. This may at least in part explain the different
DR associations observed in various populations .
Some few DR7' CD patients have been reported to be negative forDR3 orDR5
(2, 3) . It needs to be investigated whether these individuals carry the DQA1 and
DQBI genes conferring high susceptibility forCD. There has also been reported
CD patients who are DR3 - and DR7 - . These patients have all been DR4' (16) .
This was also the case of our DR3- and DR7- patient, whose DNA did not hy-
bridize with the DQAl-2 and DQBI-2 probes . The reason why these "odd" patients
are susceptible toCD is at presentunknown . One possibility mightbe that two different
gluten peptides are able to precipitate CD. One peptide may interact with the par-
ticularDQ a/ß heterodimer suggested by our studies, while another may interact
withaDR4-associated class II molecule . Evidence forasimilarmechanism has recently
been given for the MHC-associated disorder experimental allergic encephalomy-
elitis (EAE) in mice (17) .
Several reports have recently indicated an association between CD and certain
genomic DP polymorphisms (18, 19) . At present it is not clear whether both DQ
and DP genes might contribute to susceptibility to CD or whether the DP associa-
tions are secondary to the DQ association .
FIGURE 2 .
￿
Hybridization of the DQAI-2 and DQBI-2 ASO probes to Taq I restriction frag-
ments of genomicDNA from 25 CD patients and three homozygous cell lines . Thehomozygous
cell lines were tested in the outer three right lanes : DR3/3, VAVY DRwll/wll,JVM; andDRw8/w8,
BM9 . Homozygosity ofDR alleles for some patients was established by family typing . "w" desig-
nations have been omitted for the DRwll, DRw12, DRw6, and DRw8 specificities .348
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DNA sequencing of exon regions have revealed identical nucleotide sequences of
the DQAI genes ofthe DR3DQw2 and DR5DQw7 haplotypes, except one substitu-
tion in the 5'-untranslated region and identical nucleotide sequences of the first do-
main of the DQBI genes of the DR3DQw2 and DR7DQw2 haplotypes (6-9). This
indicates a common origin ofthese genes. Sharing ofintron polymorphisms revealed
by RFLP analysis supports this assumption (20). Several reports suggest that estab-
lished haplotypes have arisen by crossing over in the region between the DQAI and
DQBI genes (7, 21). We believe that the DR3DQw2 haplotype either has contributed
to the formation of, or has been formed by, the DR7DQw2 and DR5DQw7 haplo-
types by a crossing over event (Fig. 1) . The genetic information of the DR3DQw2
haplotype is thus reestablished in DR5DQw7/DR7DQw2 heterozygotes though the
genes are split between two chromosomes. Susceptibility to CD probably depends
on interaction between genes that on the DR3DQw2 haplotype are separated by
the putative crossover site. Theoretically this gene interaction may involve any HLA-
linked genes, for instance, regulatory genes. However, the DQA1 and DQB1 genes
are very good candidates since their products form heterodimers and since they are
situated close to the crossover site.
The DQa chain encoded by the DRw8DQw4 haplotype is similar but not iden-
tical to the DQa chain encoded by the CD-associated DR3DQw2 and DR5DQw7
haplotypes. DNA sequencing of the first domains have only revealed disparities in
residues 69 and 75 (6, 7, 13). No excess of DR7/DRw8 heterozygotes among CD
patients has been reported . The model for the three-dimensional structure of class II
molecules suggests that both residue 69 and 75 are involved in binding of foreign
antigen (22). Interestingly, serine at residue 75 is unique for the DQa chain of the
DR3DQw2 and DR5DQw7 haplotypes. Binding of gluten peptides to class II mole-
cules is presumably related to the pathogenesis ofCD. Our data indicate that a par-
ticular DQ a/0 heterodimer plays a decisive role in this respect where residues on
both the a and 0 chains participate and where residues 69 and 75 on the a chain
may have critical roles.
Summary
Typing of DNA from 94 unrelated children with celiac disease (CD) with HLA-
DQAI and -DQB1 allele-specific oligonucleotide probes revealed that all but one
(i .e., 98.9%) may share a particular combination ofa DQAI and a DQB1 gene. These
genes are arranged in cis position on the DR3DQw2 haplotype and in trans position
in DR5DQw7/DR7DQw2 heterozygous individuals. Thus, most CD patients may
share the same cis- or trans-encoded HLA-DQ a/0 heterodimer.
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